Lead Opinion
Opinion for the Court by Circuit Judge ROGERS.
Concurring opinion by Circuit Judge KAVANAUGH.
Sharon Rollins’s son committed suicide using a gun provided by his employer while he was taking prescribed medication manufactured and distributed by two pharmaceutical companies. On appeal from the dismissal of her wrongful death and survival action against the employer and pharmaceutical companies, Rollins presents three issues. First, she contends that the district court erred in ruling she failed to state a claim of negligence against the employer when the court invoked, sua sponte, District of Columbia law that suicide is an intervening and independent cause of death subject to limited exceptions that were inapplicable. Alternatively, she urges certification of the negligence-liability question to the D.C. Court of Appeals. Finally, she disputes the district court’s ruling that the complaint failed to state a plausible claim of products liability against the pharmaceutical companies and contends that the court then erred in denying her leave to amend the complaint. For the following reasons, we must conclude that these contentions are unpersuasive, and we affirm.
I.
Devin Bailey, Rollins’s son, had a history of mental illness. Accepting as true the factual allegations in the complaint, see Thompson v. District of Columbia,
In May 2008, Bailey voluntarily admitted himself to Washington Adventist Hospital in Maryland, where doctors prescribed him the antipsychotic drug ABI-LIFY®. Compl. ¶ 21. An accompanying “black-box warning” stated: “Children, adolescents, and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders are at increased risk of suicidal thinking and behavior. (5.2).” Compl. ¶ 23. Section 5.2 warns of “long-standing concern” about inducing worsening of depression and emergence of suicidality during early phases of treatment. Compl. ¶ 23. Bailey was discharged from the Hospital after about a week with instructions to take 20 mg of ABILIFY® daily, along with Prolixin to improve compliance. Compl. ¶ 24. In July and August he received additional prescriptions for ABILIFY® with instructions to increase the dosage to 30 mg daily, the maximum dosage. Compl. ¶ 25. ABILIFY® is manufactured and distributed in the United States by Otsuka America Pharmaceutical, Inc. (“Otsuka”), and Bristol-Myers Squibb Company (“Bristol-Myers”). Compl. ¶¶ 3-4.
In September 2008, Bailey applied for a job with Wackenhut Services, Inc., a contractor that provides security services to the federal government. Compl. ¶¶ 6, 26. Wackenhut hired him the following month as an armed security guard at Walter Reed Army Medical Center. Compl. ¶ 27. The offer of employment was contingent on completion of a “weapons qualification” and “criminal justice screening.” Compl. ¶ 27. In early November, Wackenhut’s National Research Center prepared a background screening report stating there was an outstanding September 10, 2007 arrest warrant for Bailey for failing to appear in court on “UNDISPOSED” assault and weapon charges. Compl. ¶¶ 28-29. Although the report was forwarded to the Field Manager and Chief of Guards who extended the offer of employment to Bailey, Wackenhut did not follow up on this information. Compl. ¶¶ 28, 30. Neither did Wackenhut obtain Bailey’s military service record. Compl. ¶ 34. Instead, Wackenhut tested Bailey’s firearms proficiency and issued him a gun to use in his work. Compl. ¶¶ 31-32. On November 15, 2008, Bailey received a “Diploma” declaring him a “graduate” of Wackenhut’s “Security Officer Course.” Compl. ¶ 35.
On December 9, 2008, Bailey shot and killed himself with a work-issued gun while
Rollins, individually and as representative of her son’s estate, filed suit in the D.C. Superior Court against Wackenhut, Otsuka, and Bristol-Myers. The complaint alleged that Wackenhut negligently issued Bailey a gun without adequately investigating his background and mental health history, Compl. ¶40, and that the pharmaceutical companies were strictly liable for manufacturing and distributing ABILIFY® “in a defective condition unreasonably dangerous to users and consumers, and particularly young adults such as Devin Bailey.” Compl. ¶ 43. Rollins sought compensatory damages of $1 million each for wrongful death and for survival on behalf of Bailey’s estate against all defendants, and $3 million in punitive damages against Wackenhut. On January 11, 2010, the defendants removed the lawsuit to the federal court, based on diversity jurisdiction, 28 U.S.C. §§ 1332, 1441. The pharmaceutical companies filed answers to the complaint the same day. The following week, on January 20, 2010, they moved to dismiss the complaint pursuant to Federal Rule of Civil Procedure 12(c). Wack-enhut, which had not filed an answer, moved for dismissal pursuant to Federal Rule of Civil Procedure 12(b)(6). Rollins opposed the motions.
The district court dismissed the complaint against Wackenhut for failure to state a claim pursuant to Rule 12(b)(6) and granted judgment on the pleadings to the pharmaceutical companies pursuant to Rule 12(c). Rollins v. Wackenhut Servs.,
II.
Rollins alleged that her son’s employer, Wackenhut, violated a special relationship and duty of protection it owned to her son by “carelessly and negligently” (1) failing to investigate the charges listed on its screening report and the information in his military service record; (2) issuing him a gun when it should have known that he was prohibited from possessing a weapon under federal law; and (3) allowing him to possess the gun for over a month. Compl. ¶ 40. The district court rejected Wacken-hut’s argument, citing Grillo v. National Bank of Washington,
The district court may sua sponte dismiss a claim pursuant to Rule 12(b)(6) without notice where it is “patently obvious” that the plaintiff cannot possibly prevail based on the facts alleged in the complaint. Baker v. Dir., U.S. Parole Comm’n,
On appeal, Rollins acknowledges the general rule under District of Columbia law against negligence liability for suicide, and appears to concede that her claim against Wackenhut does not fall within the irresistible impulse exception “as traditionally understood,” Reply Br. 5 n.2. Rather, she contends, her claim falls within the second exception because Wackenhut assumed a “special relationship” with her son by issuing him a gun outside the normal firearms-distribution process. See Compl. ¶ 40. As Rollins sees it, Wackenhut puts its employees through a private background screening in lieu of the normal background checks that would ordinarily adhere to purchases made at licensed firearms dealers. Rollins’s approach extends the special relationship exception far beyond its moorings.
The Restatement (Second) of Torts § 314A(4) explains that a special duty is imposed where a defendant “takes the custody of another under circumstances such as to deprive the other of his normal opportunities for protection.” As interpreted by the D.C. Court of Appeals, the special relationship exception applies where an institution or treatment facility, such as a hospital or jail, assumes physical custody over an individual. Johnson,
Rollins maintains, nonetheless, that the district court erred by excluding the possibility that other exceptions to the general rule in Peters may exist. For example, Rollins alleged that if Wackenhut had properly investigated Bailey’s background, it would have discovered that he was prohibited from possessing a firearm under 18 U.S.C. § 922(g). See Compl. ¶¶ 32-33. That provision prohibits firearms possession by any “fugitive from justice,” “mental defective,” or person “who has been committed to a mental institution.” 18 U.S.C. § 922(g)(2), (4). The district court noted that other courts had generally rejected suicide negligence claims premised on violations of § 922(g) or other gun control statutes. Rollins,
The D.C. Court of Appeals has not yet addressed a case of negligent firearm distribution that resulted in suicide but it has, since Knight and Crown were decided, affirmed a broad general rule against negligence liability for suicide. See Johnson,
B.
Rollins’s suggestion, therefore, that this court should certify two questions
Rollins’s hypothesis that the D.C. Court of Appeals might adopt other exceptions to the general rule against negligence liability in cases of suicide, citing Kivland v. Columbia Orthopaedic Group, LLP,
III.
Rollins sought to hold the two pharmaceutical companies strictly liable under the rule in the Restatement (Second) of Torts § 402A, alleging that:
By manufacturing and distributing ABILIFY® within the United States, despite its known risks of increasing suicidality in certain patients, Defendants Otsuka America and Bristol-Myers are liable for selling a product in a defective condition unreasonably dangerous to users and consumers, and particularly young adults such as Devin Bailey....
Compl. ¶ 43. The district court granted the pharmaceutical companies’ motions to dismiss pursuant to Rule 12(c) on the ground that Rollins failed to allege sufficient facts to state a plausible products liability claim. Rollins,
A.
Under the Supreme Court’s rearticulation of pleading requirements in Ashcroft v. Iqbal,
The D.C. Court of Appeals has recognized three distinct categories of defective products under section 402A of the Restatement (Second) of Torts: “(1) a manufacturing defect; (2) an absence of sufficient warnings or instructions; or (3) an unsafe design.” Warner Fruehauf Trailer Co. v. Boston,
B.
Rollins’s second response, that the district court erred by denying her leave to amend the complaint, is without merit. Federal Rule of Civil Procedure 15(a) provides that a district court “should freely give leave [to amend] when justice so requires.” Fed.R.Civ.P. 15(a)(2). But Rollins failed to comply with the law of this circuit by filing a motion for leave to amend her complaint and attaching a proposed amended complaint. Belizan v. Hershon,
To the extent Rollins separately objects, summarily, that the district court erred in dismissing her claim against the pharmaceutical companies with prejudice, Federal Rule of Civil Procedure 41(b) provides, in part, that “[ujnless the dismissal order states otherwise, [an involuntary dismissal] — except one for lack of jurisdiction, improper venue, or failure to join a party under Rule 19 — operates as an adjudication on the merits.” See Costello v. United States,
The Firestone standard is met here. The district court, in denying Rollins’s request for leave to amend her complaint as “futile,” found that Rollins “has not indicated that she will be able to plead sufficient facts to state a claim for relief.” Rollins,
Accordingly, we affirm the order dismissing the complaint.
Notes
. Rollins’s two questions are:
(1) Under District of Columbia law, may a plaintiff recover for the wrongful death of a person who committed suicide, against a third party that gave that person the firearm used in that suicide, when the third party knew or should have known that the person was prohibited by law from possessing a firearm?
(2) Under District of Columbia law, and under the facts set forth in the Complaint, may a plaintiff recover for the wrongful death of a person who committed suicide, where the person committing suicide had*129 an impairment that limited the suicide victim’s ability to appreciate his peril or encounter it purposely, in the form of a prescribed medication that had a recognized risk of increased suicidality?
Appellant’s Br. 38.
. Comment k, regarding "unavoidably unsafe products,” as is “especially common in the field of drugs,” in part states that the product is "not defective, nor is it unreasonably dangerous” where it is "properly prepared, and accompanied by proper directions and warning.” Restatement (Second) of Torts § 402A, Comment k.
Concurrence Opinion
concurring:
I join the Court’s thorough opinion and add one observation about the state of this Circuit’s law on dismissals under Rule 12(b)(6) of the Federal Rules of Civil Procedure.
As the Court correctly explains, when a district court grants a Rule 12(b)(6) motion to dismiss for failure to state a claim, that dismissal “operates as an adjudication on the merits” under Rule 41(b) “[ujnless the dismissal order states otherwise.” And “an adjudication on the merits” is synonymous with a dismissal with prejudice. See Semtek International Inc. v. Lockheed Martin Corp.,
In this case, the District Court’s dismissal order did not state whether it was with or without prejudice. Under Rule 41(b), we thus must construe the order as a dismissal with prejudice.
That in turn raises the question of when a dismissal with prejudice under Rule 12(b)(6) is permissible. Rule 41(b) also answers that question. By providing that Rule 12(b)(6) dismissals are with prejudice unless the district court in its discretion states otherwise, Rule 41(b) indicates that Rule 12(b)(6) dismissals are typically with prejudice and do not require particular justification by the district court. See Okusami v. Psychiatric Institute of Washington, Inc.,
Any potential unfairness that could otherwise result from this procedural framework is addressed by the Rules in two ways. First, Rule 15(a) provides that if a defendant files a motion to dismiss under Rule 12(b)(6) for failure to state a claim, the plaintiff may amend the complaint as a matter of course within 21 days of service of the motion to dismiss. That aspect of Rule 15(a) ensures, among other things, that the plaintiff has an opportunity to amend a complaint so as to avoid dismissal based on a technicality or readily corrected error that the defendant has identified. Moreover, under Rule 15(a), a district court in its discretion also may grant leave for a plaintiff to amend a complaint even outside the time period for amending as a matter of course. Second, under Rules 41(b) and 12(b)(6), a district court has discretion to dismiss a complaint without prejudice when the district court concludes that the circumstances so warrant. In short, Rules 12(b)(6), 15, and 41(b) work in tandem to establish a fair and efficient process for civil plaintiffs and defendants alike.
But as District Judge Bates has perceptively noted, this Court’s case law on Rule 12(b)(6) dismissals is not fully aligned with the Rules. See In re Interbank Funding Corp. Securities Litigation,
In any event, I join the Court’s opinion here, which correctly resolves and analyzes this case under our existing precedents.
